Related Experiment Video
Updated: Jan 27, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma
Rodney Luwor1, Andrew P Morokoff1,2, Stephanie Amiridis1,3
1a Department of Surgery , The University of Melbourne, The Royal Melbourne Hospital , Parkville , Australia.
Abstract:
Glioma stem cells (GSCs) play major roles in drug resistance, tumour maintenance and recurrence of glioblastoma. We investigated inhibition of the GTPase dynamin 2 as a therapy for glioblastoma. Glioma cell lines and patient-derived GSCs were treated with dynamin inhibitors, Dynole 34-2 and CyDyn 4-36. We studied about cell viability, and GSC neurosphere formation in vitro and orthotopic tumour growth in vivo. Dynamin inhibition reduced glioblastoma cell line viability and suppressed neurosphere formation and migration of GSCs. Tumour growth was reduced by CyDyn 4-36 treatment. Dynamin 2 inhibition therefore represents a novel approach for stem cell-directed Glioblastoma therapy.
Insights
Inhibiting dynamin 2 in glioblastoma reduces cancer cell viability and tumor growth. This offers a new therapeutic strategy targeting glioma stem cells for glioblastoma treatment.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Glioma stem cells (GSCs) are crucial drivers of glioblastoma (GBM) drug resistance, tumor maintenance, and recurrence.
- Targeting GSCs is a promising strategy for developing more effective GBM therapies.
Purpose of the Study:
- To investigate the therapeutic potential of inhibiting GTPase dynamin 2 in glioblastoma.
- To evaluate the effects of dynamin inhibitors on glioblastoma cell viability, GSC behavior, and tumor growth.
Main Methods:
- Treatment of glioblastoma cell lines and patient-derived GSCs with dynamin inhibitors (Dynole 34-2, CyDyn 4-36).
- Assessment of cell viability, GSC neurosphere formation, and migration in vitro.
- Evaluation of orthotopic tumor growth in vivo.
Main Results:
- Dynamin inhibition significantly reduced glioblastoma cell line viability.
- Inhibitors suppressed GSC neurosphere formation and migration.
- Treatment with CyDyn 4-36 led to reduced tumor growth in vivo.
Conclusions:
- Dynamin 2 inhibition demonstrates efficacy against glioblastoma.
- Targeting dynamin 2 represents a novel, stem cell-directed therapeutic approach for glioblastoma.
Related Concept Videos
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Feedback Inhibition
Adult Stem Cells
Embryonic Stem Cells
Induced Pluripotent Stem Cells
Enzyme Inhibition

